Interaction of talinolol and sulfasalazine in the human gastrointestinal tract

Eur J Clin Pharmacol. 1992;42(4):461-2. doi: 10.1007/BF00280137.

Abstract

The absorption of talinolol (TA) 50 mg was investigated without and together with the co-administration of sulfasalazine (SASP) 4 g in 11 healthy young volunteers, in order to clarify gastrointestinal transit of TA. Without SASP, the tmax of TA was 2.8 h, Cmax was 112 ng.ml-1 and the half life was 12 h; the AUCo-t was 958 ng.ml-1.h. In the case of concomitant administration of SASP, TA was found only in serum from 3 individuals, with a Cmax of 23 ng.ml-1 and a mean AUCo-t of 84 ng.ml-1.h. TA was not detectable in 5 subjects and it was at the limit of detection (2 ng.ml-1) in 3 subjects. Pharmacokinetic analysis was not possible in any of those individuals. The reason for the interaction appears to be the adsorption of TA by SASP. An interval of 2-3 h should elapse between giving SASP and other drugs.

Publication types

  • Comparative Study

MeSH terms

  • Adrenergic beta-Antagonists / administration & dosage
  • Adrenergic beta-Antagonists / blood
  • Adrenergic beta-Antagonists / pharmacokinetics*
  • Adult
  • Digestive System / metabolism*
  • Drug Interactions
  • Female
  • Humans
  • Male
  • Middle Aged
  • Propanolamines / administration & dosage
  • Propanolamines / blood
  • Propanolamines / pharmacokinetics*
  • Sulfasalazine / administration & dosage
  • Sulfasalazine / blood
  • Sulfasalazine / pharmacokinetics*

Substances

  • Adrenergic beta-Antagonists
  • Propanolamines
  • talinolol
  • Sulfasalazine